Tandem Diabetes Care (NSDQ:TNDM) won a medical device license from Health Canada last week for its t:slim X2 insulin pump.
The device integrates directly with Dexcom‘s (NSDQ:DXCM) G5 continuous glucose monitor and is the only system of its kind approved in Canada, according to the San Diego, Calif.-based company.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem wins approval for insulin pump in Canada appeared first on MassDevice.
from MassDevice https://ift.tt/2RPUtfu
Cap comentari:
Publica un comentari a l'entrada